MEDXFMedexus Pharmaceuticals Inc

$2.78
$0.1225
(4.22%)
Today
Updated: 03:59 PM EDT
EarningsJul 2
Mkt Cap$89.71M
Vol6,000.00
50

Neutral Sentiment

How do you feel about MEDXF?

About

Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
91

Frequently Asked Questions

What is Market Cap of Medexus Pharmaceuticals Inc?
What is the 52-week high for Medexus Pharmaceuticals Inc?
What is the 52-week low for Medexus Pharmaceuticals Inc?
What is Medexus Pharmaceuticals Inc stock price today?
What was Medexus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Medexus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Medexus Pharmaceuticals Inc?
What is the 50-day moving average of Medexus Pharmaceuticals Inc?
How many employees does Medexus Pharmaceuticals Inc have?

Latest MEDXF News

View
Top Discussions

Advertisement|Remove ads.